AEGiS-GMHC: BULLETIN: Less Costly/Better PCP Prevention Gay Men's Health CrisisImportant note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.
Click here to return to Gay Men's Health Crisis main menu
DonateNow
Print this Article


BULLETIN: Less Costly/Better PCP Prevention

Gay Men's Health Crisis Treatment Issues, Vol. 5, No. 7 - October, 1991


Trimethoprim/sulfamethoxazole (brand names, Bactrim or Septra) is a drug for preventing Pneumocystis carinii pneumonia (PCP) which has recently been deemed superior to the standard (and significantly more expensive) treatment, aerosolized pentamidine (AP). This news comes from the results of a federally-funded study (ACTG #021), in which the risk of recurrent PCP was found to be 3.25 times greater in patients taking AZT with AP than in patients taking AZT with Bactrim or Septra. Some people experience severe allergies to Bactrim or Septra, as they are similar sulfa drugs both made of trimethoprim/sulfamethoxazole (TMP/SMX). For those without sulfa allergies, the savings from taking Bactrim or Septra may reach $3,000 per patient per year.

Copyright (c) 1991 - Gay Men's Health Crisis. Non-commercial reproduction encouraged. Distributed by AEGIS, your online gateway to a world of people, knowledge, and resources. Direct Dial: v.34+: 714.248.2836; v.120/ISDN: 714.248.0433 Internet: telnet:aegis.com www: www.aegis.com


911001
GM050711


Copyright © 1991 - Treatment Issues. Reproduced with permission. Treatment Issues is published twelve times yearly by GMHC, Inc. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. GMHC Treatment Issues, The Tisch Building, 119 West 24th Street, New York, NY 10011  fredg@gmhc.org  http://www.gmhc.org

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .